BSX News 11.44 10/16/2014 04:35:35 Boston Scientific Corp (B

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Boston Scientific Corp (BSX) 11.44 $BSX

Next Support Level for Boston Scientific (BSX) is $11.29
Comtex SmarTrend(R) - Wed Oct 15, 9:28AM CDT
Shares of Boston Scientific (NYSE:BSX) have bearishly opened below the pivot of $11.68 today and have reached the first support level of $11.43. Investors may be interested in a cross of the next downside pivot targets of $11.29 and $10.90.
BSX: 11.44 (-0.12)

China Interventional Cardiovascular Device Industry Report 2014-2017
M2 - Wed Oct 15, 8:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vk2z4c/china) has announced the addition of the "China Interventional Cardiovascular Device Industry Report,2014-2017" report to their offering. The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing year after year, thereby promoting the development of domestic percutaneous coronary intervention (PCI) market. PCI cases in China totaled 454,505 in 2013, up 16.9% from a year earlier; meanwhile the interventional cardiovascular device industry there was worth RMB20.12 billion. At present, half of the Chinese interventional cardiovascular device industry is dominated by domestic companies led by MicroPort, Lepu Medical, Lifetech Scientific, and Dalian Yinyi. In 2013, 53.4% of the Chinese market was controlled by domestic companies, 31.2% by foreign counterparts represented by Johnson & Johnson, Medtronic, Boston Scientific, Abbott, B. Braun and Terumo, and 15.4% by those invested by Hong Kong, Macao and Taiwan. Affected by the implementation of Regulations on the Centralized Procurement of High-value Medical Consumables, purchase price of interventional cardiovascular devices will continue to decline, further squeezing profit margins of relevant companies. However, the substantial decline in prices will enable more patients to receive PCI, thus helping the industry maintain a fairly rapid growth rate. It is expected that the Chinese interventional cardiovascular device market will worth RMB41.2 billion by 2017. China Interventional Cardiovascular Device Industry Report, 2014-2017 focuses on the following: - Status quo of China interventional cardiovascular device industry, including overview, market demand, import & export, competitive landscape and entry barriers; - Development environment of China interventional cardiovascular device industry, embracing macro environment, policy climate and upstream & downstream sectors; - Status quo, competitive landscape, etc. of China interventional cardiovascular device market segments, covering coronary stent, balloon catheter, catheter, guidewire, sheath group and auxiliary devices; - Operation, interventional cardiovascular device business, etc. of 6 foreign and 12 Chinese interventional cardiovascular device companies. Key Topics Covered: 1. Overview of Interventional Cardiovascular Device Industry 2. Status Quo of China Interventional Cardiovascular Device Industry 3. Development Environment of China Interventional Cardiovascular Device Industry 4. Market Segments of China Interventional Cardiovascular Device Industry 5. Foreign Companies in China 6. Major Domestic Companies 7 Forecast and Outlook Companies Mentioned - Abbott Laboratories - AmsinoMed Medical Device - B. Braun - Boston Scientific - Dalian Yinyi - Demax Medical - JW Medical - Johnson & Johnson - Lepu Medical - Lifetech Scientific - Medtronic - MicroPort - Neich Medical (Shenzhen) - SCW Medicath - Sino Medical - Starway Medical - Synexmed - Terumo For more information visit http://www.researchandmarkets.com/research/vk2z4c/china
BSX: 11.44 (-0.12), JNJ: 98.21 (+1.20), ABT: 40.01 (-1.05), MDT: 62.25 (-1.26)

U.S. Market for Soft Tissue Reinforcement and Regeneration 2015
M2 - Wed Oct 15, 5:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/69mg7x/u_s_market_for) has announced the addition of the "U.S. Market for Soft Tissue Reinforcement and Regeneration 2015" report to their offering. The U.S. market for soft tissue reinforcement and regeneration includes medical graft devices that are designed to reinforce and regenerate soft tissues. Soft tissues are defined as aggregations of similarly specialized cells which collectively function to connect, support or surround other structures and organs of the body. These tissues include tendons, ligaments, fascia, skin, fibrous tissues, fat, synovial membranes, muscles, nerves and blood vessels. Collagen, the most abundant protein in mammals, is one of the characteristic elements inside the extracellular matrix of soft tissue and, as such, plays a critical role in soft tissue repair. Since soft tissue essentially makes up the majority of a person and there are countless medical conditions associated with soft tissue problems, a select group of large markets related to soft tissue repair will be covered in this report, including breast reconstruction, hernia repair, dural repair, vaginal slings, skin repair, sports medicine and tendon reinforcement, and dental soft tissue regeneration. There are three primary classes of soft tissue repair devices; - Allografts - Xenografts - Alloplasts Key Topics Covered: 1. Executive Summary 2. Research Methodology 3. U.S. Soft Tissue Reinforcement And Regeneration Market 4. Procedures 5. Breast Reconstruction Market 6. Hernia Repair Market 7. Dural Repair Market 8. Vaginal Sling Market 9. Skin Repair Market 10. Sports Medicine And Tendon Reinforcement Market 11. Dental Soft Tissue Regeneration Market 12. Abbreviations Companies Mentioned - Aesculap/B. Braun - American Medical Systems - Arthrex - Atrium Medical - BioHorizons - Boston Scientific - C. R. Bard - Citagenix - Coloplast - Cook Medical - Covidien - Dentsply - Depuy Synthes - Ethicon - Geistlich - Gore Medical - Integra LifeSciences - LifeCell - Medline - Medtronic - MiMedx - Organogenesis - Osiris - RTI Biologics - Smith & Nephew - Stryker - Synovis/Baxter - Systagenix - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/69...market_for
BSX: 11.44 (-0.12), SNN: 29.81 (-1.13), RTIX: 3.69 (+0.03), MDT: 62.25 (-1.26)

The Canadian Pain Coalition States Urgency to Improve Chronic Pain Awareness and Access to Multidisciplinary Treatment Options
CNW Group - Tue Oct 14, 10:17AM CDT
The Painful Truth Survey Reveals 72% of Chronic Pain Sufferers who have sought treatment are still in pain for 12 hours or more each day, even after many have tried several treatments
BSX: 11.44 (-0.12)

Affordable Housing Project, Lawsuit Settlement, Drug Review, and Earnings Release Schedules - Research Reports on UnitedHealth, Bristol-Myers, Boston Scientific, Abbott and Illumina
PR Newswire - Tue Oct 14, 7:55AM CDT
Today, Analysts Review released its research reports regarding UnitedHealth Group Inc. (NYSE: UNH), Bristol-Myers Squibb Company (NYSE: BMY), Boston Scientific Corporation (NYSE: BSX), Abbott Laboratories (NYSE: ABT) and Illumina Inc. (NASDAQ: ILMN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7151-100free.
BSX: 11.44 (-0.12), ABT: 40.01 (-1.05), UNH: 82.16 (-0.66), ILMN: 153.59 (+4.47), BMY: 48.96 (+0.04)

Global Ablation Technologies Market Outlook 2014 - 2020
M2 - Tue Oct 14, 4:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z8pb7c/ablation) has announced the addition of the "Ablation Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The global market for ablation technologies market has been studied on the basis of application type and technologies type. The application segment has been sub-segmented into these prominent categories namely cardiovascular, gynecology, pain management, oncology, urology, ophthalmology and others. Whereas, the ablation technologies market has been fragmented into radiofrequency, light/laser, electrical, ultrasound, microwave, cryotherapy and others. RF ablation is the most established device type, but ultrasound ablation and cryoablation are growing rapidly owing to advantages associated such as minimal damage to associated tissues among others. Cryoablation devices are the only kind of ablation device that can be used to treat prostate cancer. Urologists and interventional radiologists both use cryoablation to treat kidney cancer using differing techniques. As per an analysis by Center for Disease Prevention and Control (CDC) approximately 5.1 million people face heart failure every year of which one in nine deaths in 2009 were primarily due to cardiac arrhythmia. As per WHO projection, approximately 32 million people are living with some form cancer causing 8 million deaths across the world which clearly depicts scope of opportunities for players operating in the ablation technologies market. Some of the key companies operating in this market include St. Jude Medical, Inc., Bioscience Webster Inc., Medtronic, Inc., Boston Scientific Corp, Covidien PLC and Angiodynamics, Inc. among others. The global ablation technologies market is segmented as follows: Ablation Technologies Market, by Technology: - Radiofrequency (RF) - Cryotherapy - Ultrasound or High Intensity Focused Ultrasound (HIFU) - Light or Laser - Electrical - Microwave - Others Ablation Technologies Market, by Application: - Cardiovascular - Gynecology - Oncology - Pain management - Urology - Ophthalmology - Others For more information visit http://www.researchandmarkets.com/research/z8pb7c/ablation
BSX: 11.44 (-0.12), MDT: 62.25 (-1.26), STJ: 57.28 (-2.63)

BSX January 2017 Options Begin Trading
DividendChannel.com - Mon Oct 13, 9:57AM CDT
Investors in Boston Scientific Corp. saw new options begin trading today, for the January 2017 expiration.
BSX: 11.44 (-0.12)

LINC, BSX, KNL, RBCAA, BBT Expected To Be Down Before Next Earnings Releases
M2 - Mon Oct 13, 2:39AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and December earnings reports. Lincoln Educational Services Corp (NASDAQ:LINC), Boston Scientific Corp (NYSE:BSX), Knoll Inc (NYSE:KNL), REPUBLIC BANCORP, INC. (NASDAQ:RBCAA), BB&T Corp (NYSE:BBT) are all expected to be Down Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down Before earnings are released Tuesday:
BSX: 11.44 (-0.12), RBCAA: 24.48 (+0.16), BBT: 35.96 (-1.32), KNL: 17.67 (+0.14), LINC: 2.80 (+0.03)

Insider Trading Alert - BSX, FSL And ATRO Traded By Insiders
at The Street - Fri Oct 10, 9:00AM CDT
Stocks with insider trader activity include BSX, FSL and ATRO
BSX: 11.44 (-0.12), ATRO: 45.76 (+1.06), FSL: 16.15 (+0.26)

AngioDynamics Q1 Earnings & Revenues Beat, '15 View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:00AM CDT
For fiscal 2015, AngioDynamics Inc. (ANGO) raised its adjusted per share guidance to a range of 65 to 71 cents from the prior expectation of 64 to 70 cents, on the back of stronger than anticipated first-quarter results.
BSX: 11.44 (-0.12), ANGO: 15.79 (+0.13), ERB: 2.76 (-0.11)

tw telecom announces expansion of fibre network in Minneapolis-St Paul area
M2 - Fri Oct 10, 6:56AM CDT
tw telecom (Nasdaq:TWTC), a provider of Business Ethernet and networking solutions, announced on Thursday the expansion of its existing footprint in Minneapolis with service into St Paul, as well as the business communities in the western suburbs, the northern metro areas including Anoka County and south and east through Washington County including the St Croix Valley.
BSX: 11.44 (-0.12), TWTC: 37.40 (+0.12)

Boston Scientific's Heart Implant Device Wins FDA Panel Vote - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 1:20PM CDT
Boston Scientific's (BSX) WATCHMAN Device is a catheter-delivered heart implant that blocks the left atrial appendage (LAA), so that the migration of blood clots from the LAA can be averted
BSX: 11.44 (-0.12), ICUI: 67.84 (+0.10), ZLTQ: 22.38 (+0.18), OSUR: 8.34 (+0.32)

$4.4 Billion Gastrointestinal Endoscopic Market in the U.S. and Europe Projected for 2020
GlobeNewswire - Thu Oct 09, 11:00AM CDT
via PRWEB - According to a new report by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the U.S. and European gastrointestinal endoscopic market is expected to grow to over $4.4 Billion by 2020. This market is segmented into gastrointestinal (GI) endoscopes, capsule endoscopes, stenting devices, dilation devices, endoscopic retrograde cholangiopancreatography (ERCP) devices, biopsy forceps, polypectomy snares, hemostasis devices and enteral feeding devices. Market growth will primarily be driven by an increase in demand for gastrointestinal endoscopic procedures.
BSX: 11.44 (-0.12)

FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN(TM) Left Atrial Appendage Closure Device
PR Newswire - Wed Oct 08, 6:59PM CDT
After reviewing updated data and analysis for the Boston Scientific Corporation (NYSE: BSX) WATCHMAN(TM) Left Atrial Appendage Closure (LAAC) Device, the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted in favor of the Device. By a vote of 6 to 5 (with 1 abstention) the Panel concluded that the benefits of the WATCHMAN Device outweigh the potential risks. Furthermore, the Panel voted that there is reasonable assurance that the Device is safe (12 yes to 0 no). On the question of reasonable assurance of effectiveness, the Panel vote was unfavorable (6 yes to 7 no). The Panel provided substantial input and guidance related to the proposed Indications for Use and target patient population. There was widespread agreement among the Panel members that the Device provides a much needed alternative to long-term anticoagulation for some patients. While not bound by this vote, the FDA takes Advisory Panel comments and recommendations into account when reviewing the WATCHMAN Device application. The company is committed to working with the FDA to address the Panel's comments.
BSX: 11.44 (-0.12)

Look for Shares of Boston Scientific to Potentially Pullback after Yesterday's 2.97% Rise
Comtex SmarTrend(R) - Wed Oct 08, 4:57PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $11.74 to a high of $12.15. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $12.00 on volume of 13.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BSX: 11.44 (-0.12)

SmarTrend Watching for Potential Pullback in Shares of Boston Scientific After 2.97% Gain
Comtex SmarTrend(R) - Wed Oct 08, 4:56PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $11.74 to a high of $12.15. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $12.00 on volume of 13.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BSX: 11.44 (-0.12)

Canada Gynecological Devices Market Outlook to 2020: Key players covered include Bayer, Hologic, Boston Scientific, Microsulis, Cook and Merit
M2 - Tue Oct 07, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rn2nsv/canada) has announced the addition of the "Canada Gynecological Devices Market Outlook to 2020" report to their offering. Our new report, "Canada Gynecological Devices Market Outlook to 2020", provides key market data on the Canada Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Key Topics Covered: 1 List of Tables and Figures 2 Introduction 3 Gynecological Devices Market, Canada 4 Overview of Key Companies in Canada, Gynecological Devices Market 5 Appendix Companies Mentioned: - Conceptus, Inc. - Hologic, Inc. - CooperSurgical, Inc. - Cook Group Incorporated - Utah Medical Products, Inc. - Boston Scientific Corporation - Johnson & Johnson - Merit Medical Systems, Inc. - BSD Medical Corporation For more information visit http://www.researchandmarkets.com/research/rn2nsv/canada
BSX: 11.44 (-0.12), JNJ: 98.21 (+1.20), BSDM: 0.43 (-0.04), UTMD: 51.41 (-1.25), MMSI: 12.61 (+0.18), HOLX: 23.36 (-0.56)

Australia Non-Vascular Stents Market Outlook to 2020: Key players covered include Boston Scientific, Taewoong, Merit, Cook, PNN, Teleflex and C.R. Bard.
M2 - Tue Oct 07, 5:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qz758b/australia) has announced the addition of the "Australia Non-Vascular Stents Market Outlook to 2020" report to their offering. Our new report, "Australia Non-Vascular Stents Market Outlook to 2020", provides key market data on the Australia Non-Vascular Stents market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Biliary Stents (Plastic Biliary Stents and Metal Biliary Stents (Metal Non-Covered Biliary Stents, Metal Partially Covered Biliary Stents and Metal Fully Covered Biliary Stents)), Gastrointestinal Stents (Fully Covered, Partially Covered and Non-Covered Gastrointestinal Stents), Airway Stents (Silicone Airway Stents and Metallic Airway Stents (Fully Covered and Uncovered Metallic Airway Stents) and Urinary Tract Stents ((Ureteral Stents (Metal, Polymer and Bioabsorbable Ureteral Stents), Prostate Stents (Metal, Polymer and Bioabsorbable Prostate Stents) and Urethral Stents (Metal, Polymer and Bioabsorbable Urethral Stents)). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Non-Vascular Stents market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Key Topics Covered: 1. List of Tables and Figures 2 Introduction 3 Non-Vascular Stents Market, Australia 4 Overview of Key Companies in Australia, Non-Vascular Stents Market 5 Appendix Companies Mentioned: - Boston Scientific - C. R. Bard - Cook - Olympus - Covidien - Taewoong - Merit - ConMed For more information visit http://www.researchandmarkets.com/research/qz758b/australia
BSX: 11.44 (-0.12)

Brazil Gynecological Devices Market Outlook to 2020: Key players covered include Bayer Healthcare, Hologic, Boston Scientific, Microsulis, Cook and Merit
M2 - Tue Oct 07, 5:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hxzlpw/brazil) has announced the addition of the "Brazil Gynecological Devices Market Outlook to 2020" report to their offering. Our new report, "Brazil Gynecological Devices Market Outlook to 2020", provides key market data on the Brazil Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Key Topics Covered: 1 List of Tables and Figures 2 Introduction 3 Gynecological Devices Market, Brazil 4 Overview of Key Companies in Brazil, Gynecological Devices Market 5 Appendix Companies Mentioned: - Hologic - Merit Medical Systems - Cook Group Incorporated - Johnson & Johnson - Utah Medical Products - CooperSurgical - Boston Scientific - Conceptus - Richard Wolf For more information visit http://www.researchandmarkets.com/research/hxzlpw/brazil
BSX: 11.44 (-0.12), JNJ: 98.21 (+1.20), UTMD: 51.41 (-1.25), MMSI: 12.61 (+0.18), HOLX: 23.36 (-0.56)

Canada Non-Vascular Stents Market Outlook to 2020: Key players covered include Boston Scientific, Taewoong, Merit, Cook, PNN, Teleflex and C.R. Bard
M2 - Tue Oct 07, 5:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cvxqfp/canada) has announced the addition of the "Canada Non-Vascular Stents Market Outlook to 2020" report to their offering. Our new report, "Canada Non-Vascular Stents Market Outlook to 2020", provides key market data on the Canada Non-Vascular Stents market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Biliary Stents (Plastic Biliary Stents and Metal Biliary Stents (Metal Non-Covered Biliary Stents, Metal Partially Covered Biliary Stents and Metal Fully Covered Biliary Stents)), Gastrointestinal Stents (Fully Covered, Partially Covered and Non-Covered Gastrointestinal Stents), Airway Stents (Silicone Airway Stents and Metallic Airway Stents (Fully Covered and Uncovered Metallic Airway Stents) and Urinary Tract Stents ((Ureteral Stents (Metal, Polymer and Bioabsorbable Ureteral Stents), Prostate Stents (Metal, Polymer and Bioabsorbable Prostate Stents) and Urethral Stents (Metal, Polymer and Bioabsorbable Urethral Stents)). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Non-Vascular Stents market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Key Topics Covered: 1. List of Tables and Figures 2 Introduction 3 Non-Vascular Stents Market, Canada 4 Overview of Key Companies in Canada, Non-Vascular Stents Market 5 Appendix Companies Mentioned: - Boston Scientific Corporation - Cook Group Incorporated - C. R. Bard, Inc. - Taewoong Medical Co.,Ltd. - Olympus Corporation - ConMed Corporation - Covidien plc - Applied Medical Corporation For more information visit http://www.researchandmarkets.com/research/cvxqfp/canada
BSX: 11.44 (-0.12)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Colon Cleanse Advice Deserves a Careful Read First

Updated Category News Views 93

Wellness copy can sound harmless right up until it blurs comfort guidance with health guidance. HelloNation’s feature on what to expect after a colon cleanse, drawing on Suzanne Childre of Gentle Wellness Center in Santa Monica, lays out a fairly familiar recovery script: drink water, rest, eat lightly, expect some bowel changes, and do not panic over a little fatigue....

Continue Reading
Refund Delays Are Becoming an E-Commerce Sales Risk

Updated Category News Views 176

A returned jacket can turn into a household cash-flow problem faster than retailers seem willing to admit. Seel's new survey lands at an awkward moment for online merchants: shoppers are not merely annoyed by slow refunds; many are budgeting around them. Among 1,921 U.S. adults who had shopped online in the prior six months, 63% said waiting for a retailer to receive a...

Continue Reading
First Grade Literacy Push Deserves a Harder Look Now

Updated Category News Views 130

A reading gap can become a concrete wall before anyone bothers measuring it. That is the uncomfortable point behind Ignite Reading's First Grade Promise, and it deserves more attention than another polished education announcement usually gets. At a Nov. 5 Convene 2026 gathering in Boston, 56 district and literacy leaders from six states focused on getting children reading...

Continue Reading
PG&E's $456 Million Interim Hike Faces a New Test Soon

Updated Category News Views 51

A utility can call a charge interim, but households still see the bill arrive in full. That is why the California Public Utilities Commission's unanimous approval of $456 million in interim rate recovery for Pacific Gas & Electric has landed with such rotten timing. The money is set to begin flowing from customers on January 1, 2027, while major questions about PG&E's...

Continue Reading
Lecanemab's Alpha-Syn Signal Deserves a Cooler Head

Updated Category News Views 45

Mixed pathology is where Alzheimer's investing gets uncomfortably real, and this new lecanemab readout is a decent reminder that a drug can show promise without settling the argument. Eisai and Biogen presented a Clarity AD cerebrospinal-fluid substudy at CTAD 2026 examining people with early Alzheimer's disease who also tested positive for alpha-synuclein pathology. The...

Continue Reading
CATL Builds Türkiye Battery Service Muscle in Istanbul

Updated Category News Views 43

Battery warranties look mighty impressive until a pack needs work on a Tuesday morning and nobody nearby can touch it. CATL's new NING SERVICE Experience Center in Istanbul goes straight at that unglamorous problem. The facility, announced November 19, 2026, is described as Türkiye's first dedicated battery depot repair center and an integrated sales-and-service hub. It...

Continue Reading
Compounded Peptides Demand Clearer FDA Status Answers

Updated Category News Views 73

Peptide talk has gotten muddled enough to make plain English feel revolutionary. The central point in the HelloNation article featuring wellness expert Andres Giraldo is straightforward: a compounded peptide is not FDA approved in the same product-specific manner as a commercially manufactured drug. That is not a small semantic wrinkle, and it should not be buried beneath...

Continue Reading
Lowe's Dec. 9 Conference Puts Strategy on the Clock

Updated Category News Views 148

A Calendar Entry With Real Weight December 9 is not earnings day, but it is the sort of date shareholders ought to circle anyway. Lowe's plans to hold its 2026 Analyst and Investor Conference at 8 a.m. Eastern time in New York City, with a live webcast available for those not sitting in the room. For owners of NYSE:LOW, these gatherings can be more useful than the usual...

Continue Reading
IT Tech Packaging's Going-Concern Warning Lands Hard

Updated Category News Views 76

A paper maker can survive plenty of ugly quarters; it cannot casually shrug off an auditor questioning whether it can keep operating. That is the cold part of IT Tech Packaging's Nov. 19 disclosure. Its newly filed Form 10-K for the year ended Dec. 31, 2025 carries a “Material Uncertainty Related to Going Concern” paragraph from Audit Alliance LLP. Nobody should dress...

Continue Reading
AIM Academy Accreditation Signals a Broader Quality Push

Updated Category News Views 50

Early-childhood education does not hand out many clean, easily comparable scorecards, which is precisely why AIM Academy’s new Cognia recognition deserves a closer look. The Alabama provider has earned Cognia Initial Accreditation, while its Pike Road center received Accreditation with Merit after its Initial Accreditation Review. That is not a revenue event, not a...

Continue Reading

Top 5 Most Recently Viewed Articles

Alfa Laval Enhances Gulf Coast Support with La Porte Expansion

Updated Category News Views 183

Alfa Laval Strengthens Local Support with La Porte Service Center Alfa Laval, a world leader in heat transfer, separation, and fluid handling, is proud to announce the expansion of its Service Center in La Porte, Texas. This newly expanded facility is set to bolster the support for the Gulf Coast's industrial community, demonstrating the company’s commitment to local...

Continue Reading
AgEagle Aerial Systems Achieves Impressive Q1 Financial Gains

Updated Category News Views 209

AgEagle Aerial Systems Achieves Strong Financial Results A remarkable transformation is underway at AgEagle Aerial Systems Inc. (NYSE: UAVS), a key player in unmanned aerial systems (UAS) and sensor technology. The company has announced financial results for the first quarter of fiscal year 2025, showcasing a sharp recovery and robust performance in various financial...

Continue Reading
Empowering Future Leaders: The 6th Student Research Competition

Updated Category News Views 259

Empowering Future Leaders: The 6th Student Research Competition The Fixed Income Analysts Society (FIASI), in partnership with Fordham University's Center for Research in Contemporary Finance and the O'Shea Center for Credit Analysis and Investment, is excited to announce the launch of its highly anticipated 6th Annual FIASI – Gabelli School Student Research...

Continue Reading
LALO Tequila Unveils Unique 2025 High Proof Blanco Expression

Updated Category News Views 414

Introducing the 2025 High Proof Blanco Tequila LALO Tequila proudly presents its latest creation, the 2025 High Proof Blanco, marking a significant chapter in its celebrated line of limited-edition spirits. Scheduled just in time for Hispanic Heritage Month, this release embodies the brand’s strong cultural roots while embracing modern advancements in the tequila...

Continue Reading
TaskUs, Inc. to Reveal Q3 2024 Earnings on November 7

Updated Category News Views 95

TaskUs, Inc. to Reveal Financial Results for Q3 2024 TaskUs, Inc. (Nasdaq: TASK), a prominent leader in providing outsourced digital services and advanced customer experience, will disclose its third quarter 2024 financial results following the market's closure on November 7. Conference Call and Webcast Details Management will conduct a conference call and webcast at 5:00...

Continue Reading